Zobrazeno 1 - 10
of 547
pro vyhledávání: ''
Publikováno v:
J Gastrointest Oncol
Gastric cancer progression resulting in metachronous peritoneal metastasizing is almost always associated with an adverse prognosis. This review discusses various options of preventing metachronous peritoneal metastases in radically operated gastric
Publikováno v:
J Gastrointest Oncol
Peritoneal metastasis (PM) from gastric cancer (GC) has long been regarded as the terminal disease, lacking of effective treatments. In recent 40 years, cytoreductive surgery (CRS) plus perioperative intraperitoneal chemotherapy, including hypertherm
Autor:
Ignace H. J. T. de Hingh, Jacobus W. A. Burger, Robin J. Lurvink, Simon W. Nienhuijs, Geert-Jan Creemers, Koen P. Rovers
Publikováno v:
J Gastrointest Oncol
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) is increasingly used as a palliative treatment option for patients with colorectal peritoneal metastases (CPM). The present study aimed to systematically review all clinical
Publikováno v:
Hepatobiliary Surg Nutr
OBJECTIVE: The aim of the study was to identify the survival of patients with locally advanced pancreatic cancer (LAPC) and assess the effect of surgical resection after neoadjuvant therapy on patient outcomes. BACKGROUND: An increasing number of LAP
Autor:
Joyce Wong, Crystal Kyaw
Publikováno v:
Hepatobiliary Surg Nutr
Colon cancer is currently the third most common cancer and cause of cancer-related deaths in the United States. Approximately 35–55% of patients with colorectal cancer present with metastatic disease; of these, 10–20% of patients have resectable
Publikováno v:
Hepatobiliary Surg Nutr
Post hepatectomy liver failure (PHLF) remains the most dreaded complication in major hepatectomies. Adequate future remnant liver (FRL) plays a pivotal role in prevention of PHLF. Pre-operative portal vein embolization (PVE) has become standard of ca
Publikováno v:
Hepatobiliary Surg Nutr
Colorectal cancer (CRC) is the second most common cause of cancer death in the developed world and the third most common malignancy worldwide, with more than 1 million people affected. Approximately half of this population develops colorectal liver m
Publikováno v:
Hepatobiliary Surg Nutr
An increasing number of patients with colorectal cancer (CRC) are presenting with synchronous disease to the liver. The optimal surgical approach for this complex patient group is controversial, but ultimately depends on individual patient characteri
Autor:
Kai-Uwe Lewandrowski
Publikováno v:
Journal of Spine Surgery. 6:S35-S39
Two conceptually different transforaminal endoscopic methods of accessing and decompressing the lumbar intervertebral discs have emerged over the years: the “inside-out,” and the “outside-in” technique. While the distinction between these two
Autor:
Takayuki Ibi, Eishin Hoshi, Hiroaki Morooka, Sho Horiuchi, Tomohiko Ikeya, Yoshihiko Shimizu, Yuichi Saito, Nobumasa Takahashi
Publikováno v:
J Thorac Dis
Background The Dako PD-L1 immunohistochemistry (IHC) 22C3 pharmDx and the Dako 28-8 IHC pharmDx assays were approved by the US Food and Drug Administration, as a companion diagnostic test for pembrolizumab (Keytruda, Merk, Kenilworth, NJ, USA) and a